• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载氟米龙聚合物纳米粒原位形成凝胶用于眼部炎症疾病。

In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions.

机构信息

Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028, Barcelona, Spain.

Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028, Barcelona, Spain; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain.

出版信息

Colloids Surf B Biointerfaces. 2019 Mar 1;175:365-374. doi: 10.1016/j.colsurfb.2018.11.065. Epub 2018 Nov 27.

DOI:10.1016/j.colsurfb.2018.11.065
PMID:30554015
Abstract

Thermosensitive gels have been developed and optimized in such a way that they become gels at corneal temperature and with a viscosity that allows the adequate release of the Fluorometholone (FMT)-loaded PLGA nanoparticles (NPs) in order to improve ocular anti-inflammatory efficacy against a commercial formulation. It has been shown that gels avoid burst release of the drug in the first hours with a slow and increasing profile after administration. NPs have maintained their average size and spherical shape within the gels as confirmed by transmission electron microscopy (TEM). In turn, the in-situ gelling of the formulations allows the administration in eye drops dosage form due to its state of sol at temperatures below 25 °C. Ocular tolerance studies have shown that no formulation causes eye irritation. The administration of the developed formulations has improved the precorneal residence time reflected in the ocular bioavailability, where deep tissues as aqueous humour and crystalline were reached. In conclusion, the use of thermosensitive gels for the topical application of NPs has demonstrated their effectiveness in the acute and preventive treatment of ocular inflammatory conditions.

摘要

已经开发和优化了温敏凝胶,使其在角膜温度下变成凝胶,并且具有一定的粘度,可以使载有氟米龙(FMT)的 PLGA 纳米颗粒(NPs)充分释放,以提高针对商业制剂的眼部抗炎功效。研究表明,凝胶可避免药物在最初几小时内的爆发释放,在给药后呈现缓慢且逐渐增加的释放模式。纳米颗粒在凝胶中保持其平均粒径和球形,这一点通过透射电子显微镜(TEM)得到了证实。反过来,制剂的原位凝胶化使其能够以眼药水的形式给药,因为其在 25°C 以下的温度下呈溶液状态。眼部耐受性研究表明,没有一种制剂会引起眼部刺激。所开发制剂的给药改善了角膜前停留时间,从而反映了眼部生物利用度的提高,其中包括房水和晶状体等深层组织。总之,温敏凝胶用于 NPs 的局部应用已证明其在眼部炎症性疾病的急性和预防性治疗中的有效性。

相似文献

1
In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions.载氟米龙聚合物纳米粒原位形成凝胶用于眼部炎症疾病。
Colloids Surf B Biointerfaces. 2019 Mar 1;175:365-374. doi: 10.1016/j.colsurfb.2018.11.065. Epub 2018 Nov 27.
2
Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye.载氟米龙的 PLGA 纳米粒的研制用于治疗眼前段和眼后段的炎症性疾病。
Int J Pharm. 2018 Aug 25;547(1-2):338-346. doi: 10.1016/j.ijpharm.2018.05.050. Epub 2018 May 22.
3
Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium.壳聚糖包覆的 PLGA 纳米粒增强阿托伐他汀钙的眼部抗炎疗效。
Int J Nanomedicine. 2020 Feb 28;15:1335-1347. doi: 10.2147/IJN.S237314. eCollection 2020.
4
Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.一种温度和pH触发的新型原位凝胶系统实现眼部药物的持续递送。
Drug Deliv. 2007 Nov;14(8):507-15. doi: 10.1080/10717540701606426.
5
Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.用于丁酸氢化可的松缓释的基于纳米颗粒的局部用眼科凝胶制剂
AAPS PharmSciTech. 2016 Apr;17(2):294-306. doi: 10.1208/s12249-015-0354-5. Epub 2015 Jun 18.
6
Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.用于更昔洛韦立体异构二肽前药持续释放的基于纳米颗粒的局部眼用制剂。
Drug Deliv. 2016 Sep;23(7):2399-2409. doi: 10.3109/10717544.2014.996833. Epub 2015 Jan 7.
7
Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.运用质量源于设计理念研制用于治疗眼部炎症和感染的眼用原位凝胶剂。
Drug Dev Ind Pharm. 2016 Sep;42(9):1406-23. doi: 10.3109/03639045.2015.1137306. Epub 2016 Jan 29.
8
A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.一种潜在的载药纳米粒原位凝胶,用于增强和持续眼部递送达氟沙星。
Nanotechnology. 2018 Oct 19;29(42):425101. doi: 10.1088/1361-6528/aad7da. Epub 2018 Aug 3.
9
Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.酮咯酸氨丁三醇载纳米分散体纳入温敏型原位凝胶用于延长眼部给药。
Int J Pharm. 2016 Jun 15;506(1-2):57-67. doi: 10.1016/j.ijpharm.2016.04.021. Epub 2016 Apr 26.
10
Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.经载药黏附性微球的温敏型原位凝胶眼用给药后,硫酸妥布霉素的眼部生物利用度提高和释放时间延长。
J Ocul Pharmacol Ther. 2018 Apr;34(3):287-297. doi: 10.1089/jop.2017.0079. Epub 2017 Dec 6.

引用本文的文献

1
Novel Tissue-Specific Multifunctionalized Nanotechnological Platform Encapsulating Riluzole Against Motor Neuron Diseases.新型组织特异性多功能纳米技术平台包裹利鲁唑治疗运动神经元疾病
Int J Nanomedicine. 2025 Feb 21;20:2273-2288. doi: 10.2147/IJN.S479819. eCollection 2025.
2
Antitumoral melatonin-loaded nanostructured lipid carriers.载有褪黑素的抗肿瘤纳米结构脂质载体。
Nanomedicine (Lond). 2024;19(23):1879-1894. doi: 10.1080/17435889.2024.2379757. Epub 2024 Aug 2.
3
Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
基于可生物降解聚合物的眼部疾病药物传递系统。
Int J Mol Sci. 2023 Aug 19;24(16):12976. doi: 10.3390/ijms241612976.
4
Synthesis and Evaluation of Alginate-Based Nanogels as Sustained Drug Carriers for Caffeine.基于海藻酸盐的纳米凝胶作为咖啡因缓释药物载体的合成与评价
ACS Omega. 2023 Jun 20;8(26):23991-24002. doi: 10.1021/acsomega.3c02699. eCollection 2023 Jul 4.
5
Caspofungin-Loaded Formulations for Treating Ocular Infections Caused by spp.用于治疗由 spp. 引起的眼部感染的卡泊芬净制剂
Gels. 2023 Apr 20;9(4):348. doi: 10.3390/gels9040348.
6
Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases.用于递送神经保护剂治疗眼部神经退行性疾病的纳米载体
Pharmaceutics. 2023 Mar 3;15(3):837. doi: 10.3390/pharmaceutics15030837.
7
Updates on Biodegradable Formulations for Ocular Drug Delivery.眼部给药用可生物降解制剂的研究进展
Pharmaceutics. 2023 Feb 22;15(3):734. doi: 10.3390/pharmaceutics15030734.
8
Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: , and studies.两性霉素B和乳铁蛋白组合负载的PLGA-PEG-PEI纳米粒热敏水凝胶用于潜在根除眼部真菌感染的研究: 、 及 研究
Int J Pharm X. 2023 Feb 28;5:100174. doi: 10.1016/j.ijpx.2023.100174. eCollection 2023 Dec.
9
Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy.载双氯芬酸的可生物降解纳米颗粒作为抗肿瘤和抗血管生成疗法
Pharmaceutics. 2022 Dec 28;15(1):102. doi: 10.3390/pharmaceutics15010102.
10
Assessment of Efficacy and Safety Using PPAR-γ Agonist-Loaded Nanocarriers for Inflammatory Eye Diseases.使用过氧化物酶体增殖物激活受体-γ 激动剂负载的纳米载体评估炎症性眼病的疗效和安全性。
Int J Mol Sci. 2022 Sep 23;23(19):11184. doi: 10.3390/ijms231911184.